Doing some research on MN-166 Trial Data.. It's looking like MN-221 is not the only possible hit drug in Medicinova's pipeline. Drug Addiction and the ASTHMA market combined is quite massive! Anyone do some DD on the management of this company yet?? Trail Data looking compelling to investors..